The Sansum Diabetes Research Institute, a Santa Barbara-based nonprofit, turned 75 years old on May 20 in 2019. (file photo) In an effort to change the label on its main product, Afrezza, and equip people battling diabetes with more up to date information, Westlake Village-based MannKind launched a new inhaled insulin trial — one that…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
